Clinical Trials Directory

Trials / Completed

CompletedNCT03617094

Early Percutaneous Vertebroplasty Versus Standard Conservative Treatment in Thoracolumbar Vertebral Fractures

Early Percutaneous Vertebroplasty Versus Standard Conservative Treatment in Thoracolumbar Vertebral Fractures. Monocentric, Prospective, Randomised and Compared Clinical Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
42 (actual)
Sponsor
University Hospital, Grenoble · Academic / Other
Sex
All
Age
50 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to evaluate the efficacy of carrying out early vertebroplasty procedure, compared to the standard conservative treatment (corset), in order to prevent residual deformations that could occur in complications of vertebral fractures that are medically treated using a corset. This is a monocentric, randomized, parallel group, prospective and open-label study.

Detailed description

In this study, 58 patients with a vertebral fracture no more than 10 days old (with a max of 15 days old) will be enrolled. Treatment will be randomly allocated in 2 groups: Early percutaneous vertebroplasty (EPV group) or standard conservative treatment (corset, CT group). Patients will be followed up during 3 months after treatment. They will receive standard care for a vertebral fracture at the Grenoble-Alpes University Hospital. Evaluated criteria: Vertebral kyphosis evolution, Pain, Efficacy and Quality of vertebroplasty procedure, Tolerance and observance of the standard treatment, Safety, Physical performance, Quality of life, Autonomy.

Conditions

Interventions

TypeNameDescription
DEVICEEarly percutaneous vertebroplasty (EPV)Treatment consists of percutaneous acrylic bone cement injection using a trocar under scope control and general anesthesia.
DEVICEStandard Conservative treatment (CT)Treatment consists of using a made-to-measure 3 point thoracolumbar corset,that is worn for 3 months: night and day during the first 6 week period of the treatment, and then only the day for the next 6 week period.

Timeline

Start date
2018-07-05
Primary completion
2020-10-17
Completion
2020-10-17
First posted
2018-08-06
Last updated
2023-01-06

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03617094. Inclusion in this directory is not an endorsement.